| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/12/1995 | US5474989 Drug composition |
| 12/12/1995 | US5474985 Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors |
| 12/12/1995 | US5474980 Prolonged release of biologically active somatotropins |
| 12/12/1995 | US5474979 Nonirritating emulsions for sensitive tissue |
| 12/12/1995 | US5474904 Methods of imaging cancer cells using modified C-reactive protein |
| 12/12/1995 | US5474848 Paucilamellar lipid vesicles |
| 12/12/1995 | US5474786 Multilayered controlled release pharmaceutical dosage form |
| 12/12/1995 | US5474785 Compartment containing viscosity and density increasing beneficial agent |
| 12/12/1995 | US5474784 Dispensing device |
| 12/12/1995 | US5474783 In the form of sheet; used for applying to the dermis |
| 12/12/1995 | US5474780 Monolithic maleic anhydride drug delivery systems |
| 12/12/1995 | US5474779 Compositions for aiding in the regeneration of tissue with a prolonged immunomodulating effect |
| 12/12/1995 | US5474768 Vaginal tissue moisturizing composition and method |
| 12/12/1995 | US5474764 Alkaline ophthalmic suspensions |
| 12/12/1995 | US5474760 Method of inhibiting oxidants using alkylaryl polyether alcohol polymers |
| 12/12/1995 | US5474759 Non-chlorofluorocarbon aerosol formulations |
| 12/12/1995 | US5474758 A casing, a valve stem and a diaphragm; diaphragm contains blend of polyolefin random copolymer and block copolymer of butylene-ethylene-styrene terpolymer uniformly dispersed with in polyolefin |
| 12/12/1995 | US5474718 Starch hydrolysates as sequesterers |
| 12/12/1995 | US5474547 Parkinson disease, epilepsy |
| 12/12/1995 | US5474535 Dosage and inserter for treatment of erectile dysfunction |
| 12/12/1995 | US5473966 Method for sizing transdermal patch |
| 12/12/1995 | CA2010692C Gelatin capsules containing ranitidine |
| 12/09/1995 | CA2151191A1 Cosmetic or dermatological composition consisting of an aqueous and stable dispersion of phytantrial cubic gel particles and containing a fatty chain surfactant used as a dispersing and stabilizing agent |
| 12/07/1995 | WO1995033060A1 Method of cancer treatment by p53 protein control |
| 12/07/1995 | WO1995032992A1 Synthetic peptide analogs of lung surfactant protein sp-c |
| 12/07/1995 | WO1995032945A1 Compositions and methods for treating mast-cell mediated conditions |
| 12/07/1995 | WO1995032737A1 Pharmaceutical composition |
| 12/07/1995 | WO1995032736A1 Immobilization of biologically active materials and diagnostic agents in cross-linked poly(organophosphazenes) |
| 12/07/1995 | WO1995032734A1 New methods and compounds for the selective modulation of antigen-specific t-cell responsiveness |
| 12/07/1995 | WO1995032730A1 A pharmaceutical preparation comprising glucagon |
| 12/07/1995 | WO1995032728A1 Inhibition of attachment of h. influenzae to human cells |
| 12/07/1995 | WO1995032726A1 Cyclosporin containing composition and process for the preparation thereof |
| 12/07/1995 | WO1995032715A1 Nitric oxide donor composition and method for treatment of anal disorders |
| 12/07/1995 | WO1995032713A1 Solid dispersion of thiazolidine derivative or pharmaceutical preparation comprising said dispersion |
| 12/07/1995 | WO1995032707A1 Medicinal film for the treatment of periodontitis |
| 12/07/1995 | WO1995032706A1 Virosome-mediated intracellular delivery of therapeutic agents |
| 12/07/1995 | WO1995030410A3 Transdermal device for administration through de-epithelialized skin |
| 12/07/1995 | WO1995024485A3 Coordinate in vivo gene expression |
| 12/07/1995 | DE4419724A1 Lagerstabiles und diffusionsdichtes Mikrokapselwandmaterial A shelf-stable and diffusion-tight microcapsule wall material |
| 12/07/1995 | DE4417673A1 Biodegradable hydrophobic ointment base |
| 12/07/1995 | CA2191317A1 A pharmaceutical preparation comprising glucagon |
| 12/07/1995 | CA2190610A1 Inhibition of attachment of h. influenzae to human cells |
| 12/07/1995 | CA2190598A1 Pharmaceutical composition |
| 12/07/1995 | CA2188812A1 New methods and compounds for the selective modulation of antigen-specific t-cell responsiveness |
| 12/06/1995 | EP0685457A1 Glycerol derivative, device and pharmaceutical composition |
| 12/06/1995 | EP0685234A1 Drug composition containing nucleic acid copolymer |
| 12/06/1995 | EP0685232A2 Cefixim formulation |
| 12/06/1995 | EP0685231A2 Water-dispersible tablet containing lamotrigine |
| 12/06/1995 | EP0685230A1 Stable dermatologic preparation containing mycophenolic acid |
| 12/06/1995 | EP0685228A1 Cosmetic sunscreening compositions containing a synergic mixture of filters and uses |
| 12/06/1995 | EP0685225A1 Cosmetic sunscreening compositions and uses |
| 12/06/1995 | EP0684973A1 Process for the preparation of a water-dispersible carotenoid preparation in powder form. |
| 12/06/1995 | EP0684840A1 Method of preparing colloidal aqueous solutions of active substances which are only slightly soluble in water, and a lipid for use in the method |
| 12/06/1995 | EP0684839A1 Process for preparing colloidal aqueous solutions of hardly soluble active substances |
| 12/06/1995 | EP0684834A1 Microemulsions comprising therapeutic peptides |
| 12/06/1995 | EP0684833A1 Microemulsions comprising therapeutic peptides |
| 12/06/1995 | EP0684832A1 Microemulsions containing pharmaceutical compositions |
| 12/06/1995 | EP0684823A1 Fibrinogen receptor antagonists |
| 12/06/1995 | EP0684819A1 Liquid pharmaceutical compositions based on ibuprofen |
| 12/06/1995 | EP0684816A1 5-ht 2? receptor antagonist compositions useful in treating venous conditions |
| 12/06/1995 | EP0684815A1 Drug delivery system using hollow fibers |
| 12/06/1995 | EP0684814A1 Compositions for oral delivery of active agents |
| 12/06/1995 | EP0684812A1 Condensed-phase microparticle composition and method |
| 12/06/1995 | EP0684808A1 Light stable color compositions |
| 12/06/1995 | EP0684806A1 Transmucosal delivery of macromolecular drugs |
| 12/06/1995 | EP0673259A4 A method for transplanting cells into the brain and therapeutic uses therefor. |
| 12/06/1995 | EP0647132B1 Galenic composition for topical use |
| 12/06/1995 | EP0647131B1 Dermatological agent for aiding oxygen transport in the skin |
| 12/06/1995 | EP0647129B1 Topical application composition |
| 12/06/1995 | EP0557512B1 Utilization in cosmetic or topical applications of an aqueous dispersion based on organopolysiloxanes and a crosslinked copolymer of acrylamide/neutralized 2-acrylamido 2-methylpropane sulfonic acid |
| 12/06/1995 | EP0445255B1 Treatment of conditions and disease |
| 12/06/1995 | EP0394314B2 Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes |
| 12/06/1995 | CN2214190Y Medicinal adhesive tape for treatment of haemorrhoids |
| 12/06/1995 | CN1113074A Aqueous composition |
| 12/06/1995 | CN1112838A Chinese proprietary for curing hepatitis |
| 12/06/1995 | CN1112830A Process for the preparation of proliposomes and liposomes |
| 12/06/1995 | CN1112825A Minimizing trichomadesis with anti-fungus compound and halogeno-anti-bacteria compound |
| 12/06/1995 | CN1112807A Medicinal diet health-care tea |
| 12/05/1995 | US5472982 Emulsified external treatment composition containing diclofenac sodium |
| 12/05/1995 | US5472951 Containing lipopolysaccharide having hydrophobic group linked through an amide linkage to a stereoisomeric carbon at a reducing end group of an aldose |
| 12/05/1995 | US5472950 Compositions containing cobalt hyaluronic acid complex |
| 12/05/1995 | US5472938 Pharmaceutical depot compositions containing hirudin |
| 12/05/1995 | US5472731 Protein based food product |
| 12/05/1995 | US5472715 Antifungal agent for the treatment of skin disease caused by trichophyton, eczema or various fungi, and also for activating the recovery of the skin and burns |
| 12/05/1995 | US5472714 Double-layered oxcarbazepine tablets |
| 12/05/1995 | US5472712 A drug substrate containing an active agent coated with ethyl cellulose being cured at a temperature greater than the glass transition temperature; storage stability, sustained release |
| 12/05/1995 | US5472711 Controlled release solid oral dosage form |
| 12/05/1995 | US5472710 Pharmaceutical preparation to be administered orally with controlled release of active substance and method for its manufacture |
| 12/05/1995 | US5472708 Pulsatile particles drug delivery system |
| 12/05/1995 | US5472707 High dose ranolazine formulations |
| 12/05/1995 | US5472706 Dry compositions for preparing submicron emulsions |
| 12/05/1995 | US5472705 Pharmaceutical composition containing esters of ω-3 polyunsaturated acids and their use in the topical treatment of morbid affections |
| 12/05/1995 | US5472704 Pharmaceutical controlled-release composition with bioadhesive properties |
| 12/05/1995 | US5472685 Antiplaque oral compositions |
| 12/05/1995 | US5472665 Process for treating compressed cellulose and applications thereof |
| 12/05/1995 | US5472436 Device for delivering a liquid to an eye |
| 12/05/1995 | US5472002 Cigarette filter for administering taurine by inhalation |
| 12/05/1995 | CA2047903C Calcitonin-containing emulsion for nasal administration |
| 12/05/1995 | CA2012875C Skin permeation enhancer compositions |
| 12/05/1995 | CA1337684C Filter comprising a material obtained by freeze-drying, method of preparation and use especially in pharmacy |